Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Wang

OA02.05 CK-101 (RX518), a Third Generation Mutant-Selective Inhibitor of EGFR in NSCLC: Results of an Ongoing Phase I/Ii Trial

Journal of Thoracic Oncology

English

P040 Highly Sensitivity and Fast Genetic Diagnosis by Mean of a Novel NGS-Based Resequencing Gene Panel Underlying SCLC Patients

Journal of Thoracic Oncology

English

P1.15-17 Risk Factors of Local Recurrence in EGFR-Mutant Stage III-pN2 Adenocarcinoma After Complete Resection: A Multi-Center Real-World Cohort Study

Journal of Thoracic Oncology

English

Letter: Lipid-Lowering Effect of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B-More Evidence Is Needed

Alimentary Pharmacology and Therapeutics

English

S51 Reducing Intracellular Aggregation and Improving the Secretion of Z Alpha-1 Antitrypsin

English

P022 Association Between Oral Leukoplakia and Lung Cancer: A 28-Year Follow-Up Study in the Linxian General Population Trial

Journal of Thoracic Oncology

English

P2.09-29 Automatic Lung Cancer Staging From Medical Reports Using Natural Language Processing

Journal of Thoracic Oncology

English

P1.03-21 Huaier Aqueous Extract Induces Lung Adenocarcinoma Cell Apoptosis Through Excessive Activation of MEK/ERK Signaling Pathway

Journal of Thoracic Oncology

English

P2.04-29 Preliminary Results With Tislelizumab in Chinese Patients With Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

P1.13-24 EGFR-KDD Is Rare and Demonstrates Variable Anti-Tumor Response to Tyrosine Kinase Inhibitors in East Asian NSCLC Population

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Wang

OA02.05 CK-101 (RX518), a Third Generation Mutant-Selective Inhibitor of EGFR in NSCLC: Results of an Ongoing Phase I/Ii Trial

P040 Highly Sensitivity and Fast Genetic Diagnosis by Mean of a Novel NGS-Based Resequencing Gene Panel Underlying SCLC Patients

P1.15-17 Risk Factors of Local Recurrence in EGFR-Mutant Stage III-pN2 Adenocarcinoma After Complete Resection: A Multi-Center Real-World Cohort Study

Letter: Lipid-Lowering Effect of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B-More Evidence Is Needed

S51 Reducing Intracellular Aggregation and Improving the Secretion of Z Alpha-1 Antitrypsin

P022 Association Between Oral Leukoplakia and Lung Cancer: A 28-Year Follow-Up Study in the Linxian General Population Trial

P2.09-29 Automatic Lung Cancer Staging From Medical Reports Using Natural Language Processing

P1.03-21 Huaier Aqueous Extract Induces Lung Adenocarcinoma Cell Apoptosis Through Excessive Activation of MEK/ERK Signaling Pathway

P2.04-29 Preliminary Results With Tislelizumab in Chinese Patients With Non-Small Cell Lung Cancer (NSCLC)

P1.13-24 EGFR-KDD Is Rare and Demonstrates Variable Anti-Tumor Response to Tyrosine Kinase Inhibitors in East Asian NSCLC Population